Form 4: Procter & Gamble Executive Moses Victor Javier Aguilar Reports Stock Transactions

Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, reported the acquisition and disposal of company stock and derivative securities on May 5, 2025.

Summary

• On May 5, 2025, Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, filed a Form 4.
• The form details changes in beneficial ownership of Procter & Gamble (PG) stock.
• Aguilar acquired 10,520 shares of common stock through the exercise of stock options at a price of $80.29.
• He then sold 10,520 shares of common stock at a weighted average price of $158.6692, with prices ranging from $158.65 to $158.74.
• Following these transactions, Aguilar directly owns 25,181.5688 shares of common stock.
• He also indirectly owns 6,259.8513 shares through a retirement plan trustee and 428.6033 shares through the International Stock Ownership Plan (Mexico) Trustee.
• Additionally, Aguilar was awarded 11.6758 restricted stock units (RSUs) that will be delivered in shares upon retirement.
• The stock options exercised were granted on February 28, 2019, and expire on February 27, 2026.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The exercise of stock options and subsequent sale indicates Aguilar's belief in the company's value, at least at the time the options were granted.
• The sale price of $158.6692 is significantly higher than the exercise price of $80.29, resulting in a substantial profit for Aguilar.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Comparing Aguilar's transactions to those of other executives at similar companies (e.g., Unilever, Nestle) would provide a benchmark for assessing the magnitude and frequency of insider trading activity.
• Analyzing the ratio of stock options exercised versus shares sold can offer insights into Aguilar's long-term investment strategy compared to industry peers.
• Benchmarking the weighted average sale price against the average trading volume of PG stock on May 5, 2025, can indicate the impact of Aguilar's transactions on the market.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the supply of shares in the market.
• The exercise of stock options benefits Aguilar, while the subsequent sale provides him with liquidity.

Key Dates

Keywords

Procter & Gamble, PG, stock options, Form 4, insider trading, Aguilar, restricted stock units, stock sale, stock acquisition